Shields Health Solutions’ Post

Mark your calendars for October 22nd, 1:00 PM EST! Join us for a webinar on "Introduction to the Gene and Cellular Therapy Era." We’ll delve into the latest in gene and cellular therapies, their unique challenges, and the innovative business models emerging to address them. Register now to gain insights into current therapies, payer considerations, and what’s on the horizon in this critical area of healthcare. Be part of the conversation that shapes the future of patient care. https://bit.ly/47EkSEw #ElevatingSpecialtyPharmacy #ShieldsRx

Today’s the day! Join us at 1:00 PM EST for our webinar, "Introduction to the Gene and Cellular Therapy Era." We’ll explore the latest advancements, innovative payment models, and the challenges gene and cellular therapies bring to healthcare. There’s still time to register—don’t miss out on this important conversation! https://bit.ly/47EkSEw #ElevatingSpecialtyPharmay #ShieldsRx

The next chapter of our #CRISPRlingo series offers a lesson in Latin.     In vivo translates to “within the living,” and, in the context of gene editing, it refers to a targeted approach for editing  genes within a patient’s body. Investigational in vivo #CRISPR therapies are typically delivered intravenously and designed to target specific cell types. Learn more: https://bit.ly/3LhSspB #InVivoTherapy To learn about ex vivo therapies, check out the next installment of our series. Scientia potentia est!

We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field. https://lnkd.in/exhRKaUz

✔️ Looks like it was a great week in Liverpool from the feedback - Lots of change since I last attended the BioIndustry Association (BIA) BioprocessUK at the Manchester Midland, just before I moved to India. ⏳ The big subjects then were protein therapeutic processing and the importance of yield, stability, and aggregation. The focus has shifted since then to Gene & Cell Therapies, as you might expect - how to process and manufacture these innovative medicines more efficiently to maximise patient-benefit. 🧬 Whether it be mAbs or Gene Therapies, or any of the other cutting-edge modalities being developed to improve health, Malvern Panalytical Pharmaceuticals has the biophysical tech and knowledge to de-risk and speed up your development processes. For more, please see here: https://lnkd.in/gj57ZxMi #CGT #BioprocessUK #mAb #Biologics

Interested in learning how the #AdvancedTherapies industry can enhance today's manufacturing practices to establish fully automated, digitally integrated processes? ➡️ https://buff.ly/3BthKPL Daniel Gibson, Head of Collaborations at the Cell and Gene Therapy Catapult, highlights this and more in his key takeaways from Phacilitate's recent Advanced Therapies Europe event. Read the blog ☝️ #CellTherapy #GeneTherapy #ATMPs

Customizable dashboards, real-time shipment data, detailed analytics and more. OCELLOS is the ultimate cell and gene therapy supply chain solution. Book a demo with one of our experts to learn more: https://loom.ly/XvieiLU Attending Advanced Therapies Congress next week? See OCELLOS in action at our stand: 209. #CGT #CellAndGeneTherapy #SupplyChain #SupplyChainAutomation #CGTSupplyChain #PersonalizedMedicine

New on Pharma's Almanac: PPD’s Erin Schaller and Aidan Jones discuss how the growth of cell and gene therapies have produced a myriad of logistical supply chain challenges around management of complex samples, making an experienced and expert clinical research partner more critical than ever. Read the article here: https://lnkd.in/erFU493y #clinicaltrials #clinicalsupply #logistics #celltherapy #cellandgenetherapy #clinicaltriallogistics #supplychain

The clinical research process is made up of phases - typically 4. At every phase, the goal is to determine if a treatment or drug is both SAFE and EFFECTIVE for humans. Each phase has specific goals, asks different questions and builds upon what was learned in the earlier phase(s). This video by the American Society of Gene & Cell Therapy describes the basic framework. https://bit.ly/40mUe1t #clinicaltrials #research #raredisease

A coordinated orchestration with tailored services, distribution and advanced analytics is critical to unlocking value for our CGT partners.